Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Longdan Xiegan Tang (LXT) is a classical Traditional Chinese Medicine (TCM) herbal formulation historically used to clear liver fire and drain damp-heat from the liver and gallbladder. It is a polyherbal mixture typically composed of ten botanical ingredients including *Gentiana scabra*, *Scutellaria baicalensis*, and *Gardenia jasminoides*. Modern pharmacological research indicates that LXT possesses anti-fibrotic, anti-inflammatory, and metabolic regulatory properties. Its mechanisms of action include the upregulation of Parkin-mediated mitophagy to inhibit hepatic stellate cell activation, modulation of the ACE2/Ang (1-7)/Mas axis to mitigate hepatic insulin resistance and inflammation, and activation of the AMPK-alpha pathway to regulate lipid metabolism. LXT is clinically utilized for conditions such as liver injury, fatty liver, and various inflammatory or autoimmune disorders. However, historical concerns regarding nephrotoxicity exist due to the potential inclusion of aristolochic acid-containing herbs in some formulations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on longdan xiegan tang.